Literature DB >> 27662309

Prediction of Incipient Alzheimer's Disease Dementia in Patients with Mild Cognitive Impairment.

Babak A Ardekani1,2, Elaine Bermudez1,2, Asim M Mubeen1, Alvin H Bachman1.   

Abstract

BACKGROUND: Mild cognitive impairment (MCI) is a transitional stage from normal aging to Alzheimer's disease (AD) dementia. It is extremely important to develop criteria that can be used to separate the MCI subjects at imminent risk of conversion to Alzheimer-type dementia from those who would remain stable. We have developed an automatic algorithm for computing a novel measure of hippocampal volumetric integrity (HVI) from structural MRI scans that may be useful for this purpose.
OBJECTIVE: To determine the utility of HVI in classification between stable and progressive MCI patients using the Random Forest classification algorithm.
METHODS: We used a 16-dimensional feature space including bilateral HVI obtained from baseline and one-year follow-up structural MRI, cognitive tests, and genetic and demographic information to train a Random Forest classifier in a sample of 164 MCI subjects categorized into two groups [progressive (n = 86) or stable (n = 78)] based on future conversion (or lack thereof) of their diagnosis to probable AD.
RESULTS: The overall accuracy of classification was estimated to be 82.3% (86.0% sensitivity, 78.2% specificity). The accuracy in women (89.1%) was considerably higher than that in men (78.9%). The prediction accuracy achieved in women is the highest reported in any previous application of machine learning to AD diagnosis in MCI.
CONCLUSION: The method presented in this paper can be used to separate stable MCI patients from those who are at early stages of AD dementia with high accuracy. There may be stronger indicators of imminent AD dementia in women with MCI as compared to men.

Entities:  

Keywords:  Alzheimer’s disease; Random Forest; atrophy; hippocampus; longitudinal analysis; magnetic resonance imaging; mild cognitive impairment; prediction; sex

Mesh:

Year:  2017        PMID: 27662309     DOI: 10.3233/JAD-160594

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  14 in total

1.  Early identification of MCI converting to AD: a FDG PET study.

Authors:  Marco Pagani; Flavio Nobili; Silvia Morbelli; Dario Arnaldi; Alessandro Giuliani; Johanna Öberg; Nicola Girtler; Andrea Brugnolo; Agnese Picco; Matteo Bauckneht; Roberta Piva; Andrea Chincarini; Gianmario Sambuceti; Cathrine Jonsson; Fabrizio De Carli
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-06-29       Impact factor: 9.236

2.  Association of Hippocampal Atrophy With Duration of Untreated Psychosis and Molecular Biomarkers During Initial Antipsychotic Treatment of First-Episode Psychosis.

Authors:  Donald C Goff; Botao Zeng; Babak A Ardekani; Erica D Diminich; Yingying Tang; Xiaoduo Fan; Isaac Galatzer-Levy; Chenxiang Li; Andrea B Troxel; Jijun Wang
Journal:  JAMA Psychiatry       Date:  2018-04-01       Impact factor: 21.596

3.  A new approach to symmetric registration of longitudinal structural MRI of the human brain.

Authors:  Babak A Ardekani
Journal:  J Neurosci Methods       Date:  2022-03-11       Impact factor: 2.390

4.  Predicting MCI to AD Conversation Using Integrated sMRI and rs-fMRI: Machine Learning and Graph Theory Approach.

Authors:  Tingting Zhang; Qian Liao; Danmei Zhang; Chao Zhang; Jing Yan; Ronald Ngetich; Junjun Zhang; Zhenlan Jin; Ling Li
Journal:  Front Aging Neurosci       Date:  2021-07-30       Impact factor: 5.750

5.  Effect of citalopram on hippocampal volume in first-episode schizophrenia: Structural MRI results from the DECIFER trial.

Authors:  Wei Qi; Esther Blessing; Chenxiang Li; Babak A Ardekani; Kamber L Hart; Julia Marx; Oliver Freudenreich; Corinne Cather; Daphne Holt; Iruma Bello; Erica D Diminich; Yingying Tang; Michelle Worthington; Botao Zeng; Renrong Wu; Xiaoduo Fan; Andrea Troxel; Jingping Zhao; Jijun Wang; Donald C Goff
Journal:  Psychiatry Res Neuroimaging       Date:  2021-04-07       Impact factor: 2.493

Review 6.  How random is the random forest? Random forest algorithm on the service of structural imaging biomarkers for Alzheimer's disease: from Alzheimer's disease neuroimaging initiative (ADNI) database.

Authors:  Stavros I Dimitriadis; Dimitris Liparas
Journal:  Neural Regen Res       Date:  2018-06       Impact factor: 5.135

7.  Classifying MCI Subtypes in Community-Dwelling Elderly Using Cross-Sectional and Longitudinal MRI-Based Biomarkers.

Authors:  Hao Guan; Tao Liu; Jiyang Jiang; Dacheng Tao; Jicong Zhang; Haijun Niu; Wanlin Zhu; Yilong Wang; Jian Cheng; Nicole A Kochan; Henry Brodaty; Perminder Sachdev; Wei Wen
Journal:  Front Aging Neurosci       Date:  2017-09-26       Impact factor: 5.750

Review 8.  Imaging biomarkers in neurodegeneration: current and future practices.

Authors:  Peter N E Young; Mar Estarellas; Emma Coomans; Meera Srikrishna; Helen Beaumont; Anne Maass; Ashwin V Venkataraman; Rikki Lissaman; Daniel Jiménez; Matthew J Betts; Eimear McGlinchey; David Berron; Antoinette O'Connor; Nick C Fox; Joana B Pereira; William Jagust; Stephen F Carter; Ross W Paterson; Michael Schöll
Journal:  Alzheimers Res Ther       Date:  2020-04-27       Impact factor: 6.982

9.  Discrimination and conversion prediction of mild cognitive impairment using convolutional neural networks.

Authors:  Congling Wu; Shengwen Guo; Yanjia Hong; Benheng Xiao; Yupeng Wu; Qin Zhang
Journal:  Quant Imaging Med Surg       Date:  2018-11

Review 10.  Random Forest Algorithm for the Classification of Neuroimaging Data in Alzheimer's Disease: A Systematic Review.

Authors:  Alessia Sarica; Antonio Cerasa; Aldo Quattrone
Journal:  Front Aging Neurosci       Date:  2017-10-06       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.